Are Differences in Inflammatory Markers between Patients with and without Hypertension-Mediated Organ Damage Influenced by Circadian Blood Pressure Abnormalities?

We aimed to explore the influence that the circadian blood pressure (BP) profile could exert on the correlation between some inflammatory markers and hypertension-mediated organ damage (HMOD). This was a cross-sectional study that included patients with primary arterial hypertension older than 18 years old. We included some parameters of 24 h ambulatory blood pressure monitoring collection and several inflammatory markers, as follows: platelet count (PTC), erythrocyte sedimentation rate (ESR), ultrasensitive C-reactive-protein, ferritin, fibrinogen, and uric acid. Myocardial hypertrophy, albuminuria, carotid intima-media thicknesses and ankle brachial index were assessed as HMOD presentations. Individuals were divided into two groups: patients with and without HMOD. We included 522 patients (47% women, mean age of 54 years). Multivariate logistic regression analysis showed that male patients older than 50 years old with uric acid levels above 7 mg/dL, ESR higher than 20 mm/h, fibrinogen greater than 320 mg/dL and PTC lower than 275 × 103/µL were associated with HMOD (p < 0.05). The circadian BP profile (dipper versus non-dipper pattern) did reach neither statistical significance nor influence the odds ratio of those inflammatory markers for HMOD. We found that differences in some inflammatory markers between patients with and without HMOD were not explained by a different circadian BP profile.

• Publication year

  2022

• Venue

  Journal of Clinical Medicine

• Publication date

  2022-02-25

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3390/jcm11051252PMID 35268342PMCID 8911066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2021cited by this paper
• [Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration].

  2021cited by this paper
• Analysis of inflammatory markers in patients with abnormal circadian rhythm of blood pressure

  2021cited by this paper
• ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk

  2020cited by this paper
• The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study

  2020cited by this paper
• Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper—accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020

  2020cited by this paper
• Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns.

  2020cited by this paper
• Hypertensive Mediated Organ Damage and Hypertension Management. How to Assess Beneficial Effects of Antihypertensive Treatments?

  2020cited by this paper
• The multifaceted role of fibrinogen in tissue injury and inflammation.

  2019cited by this paper
• High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes

  2019cited by this paper
• 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2019cited by this paper
• Uric acid and hypertension: a focused review and practical recommendations.

  2019cited by this paper
• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

  2019cited by this paper
• The Effect of Mean Platelet Volume/Platelet Count Ratio on Dipper and Non-Dipper Blood Pressure Status

  2019cited by this paper
• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

  2019cited by this paper
• Inflammation markers and risk of developing hypertension: a meta-analysis of cohort studies

  2019cited by this paper
• Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases.

  2018cited by this paper
• Inflammation in Salt-Sensitive Hypertension and Renal Damage

  2018cited by this paper
• Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension.

  2018cited by this paper
• 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

  2018cited by this paper
• Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

  2017cited by this paper
• Platelets and circulating CD34-positive cells as an indicator of the activity of the vicious cycle between hypertension and endothelial dysfunction in elderly Japanese men.

  2017cited by this paper
• The relationship between a blunted morning surge and a reversed nocturnal blood pressure dipping or “riser” pattern

  2017cited by this paper
• Inflammation, Immunity, and Hypertension.

  2017cited by this paper
• Platelet-derived chemokines in inflammation and atherosclerosis.

  2017cited by this paper
• European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

  2014cited by this paper
• Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension

  2014cited by this paper
• C-reactive protein and Hypertension

  2014cited by this paper
• Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension

  2014cited by this paper
• Hypertension and endothelial dysfunction: therapeutic approach.

  2012cited by this paper
• Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients

  2011cited by this paper
• Inflammation, Immunity, and Hypertension

  2011cited by this paper
• Interaction between inflammation and blood viscosity predicts cardiovascular mortality

  2010cited by this paper
• Fibrinogen-&ggr; C-Terminal Fragments Induce Endothelial Barrier Dysfunction and Microvascular Leak via Integrin-Mediated and RhoA-Dependent Mechanism

  2009cited by this paper
• Awake Blood Pressure Variability, Inflammatory Markers and Target Organ Damage in Newly Diagnosed Hypertension

  2008cited by this paper
• Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage

  2008cited by this paper
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration

  2007cited by this paper
• Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.

  2005cited by this paper
• Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002)

  2003cited by this paper
• Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Endothelial dysfunction in hypertension.

  2000cited by this paper
• Endothelial dysfunction in hypertension.

  1994cited by this paper
• Dippers and non-dippers.

  1988cited by this paper

• 24-Hour ambulatory blood pressure and C-reactive protein: a systematic review and meta-analysis.

  2026cites this paper
• Evaluating an Early Risk Model for Uncomplicated Hypertension in Pregnancy Based on Nighttime Blood Pressure, Uric Acid, and Angiogenesis-Related Factors

  2025cites this paper
• Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study

  2024cites this paper
• Implications of Inflammatory and Oxidative Stress Markers in the Attenuation of Nocturnal Blood Pressure Dipping

  2023cites this paper
• Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study

  2023cites this paper